ArticleThe Laryngoscope2026
C-Reactive Protein Serum Values in Idiopathic and Autoimmune Subglottic Stenosis.
Article in The Laryngoscope, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- C-Reactive Protein Serum Values in Idiopathic and Autoimmune Subglottic Stenosis.The Laryngoscope · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
OBJECTIVE (S): Idiopathic and granulomatosis with polyangiitis (GPA)-related subglottic stenosis (SGS) are considered distinct immune-mediated inflammatory disorders. Limited data exist on serum inflammatory markers, specifically C-Reactive Protein (CRP), for SGS diagnosis, differentiation, and prognostication. The study objective was the characterization of CRP levels in idiopathic (iSGS) and GPA-SGS to assess CRP's ability to distinguish SGS subtypes and predict SGS progression and recurrence.
methodsRetrospective review of patients with idiopathic or GPA-SGS from 2007 to 2024 at a single institution. Surgery-free interval (SFI) was calculated as the time between surgical interventions. Statistical analysis included independent t-tests, chi-squared, and univariate linear regression.
results59 iSGS and 47 GPA-SGS patients were included. CRP was elevated in 36% of iSGS and 49% of GPA-SGS patients (0.0.6 mg/dL). Mean maximum CRP was 2.7 mg/dL lower in iSGS compared to anti-neutrophil cytoplasmic antibody (ANCA)-positive GPA-SGS (p = 0.035). The maximum CRP in iSGS was 3.6 mg/dL, while 10 (21%) GPA patients had CRPs greater than 3.6 mg/dL (max = 31 mg/dL). ANCA-negative GPA-SGS mean CRP was not significantly different than iSGS or ANCA-positive GPA-SGS. CRP and SFI did not correlate on univariate linear analysis.
conclusionMild elevation of CRP is common in SGS patients. High CRP levels are more frequent in GPA-SGS, potentially aiding clinical differentiation of etiologies. However, CRP at presentation does not appear to correlate with disease recurrence in iSGS or GPA-related SGS, limiting its value as a biomarker and prognostic tool. LEVEL OF EVIDENCE: 3:
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.